异动解读 | 布鲁克股价盘中大跌13.14%，二季度业绩不及预期且下调全年展望

异动解读

Aug 04, 2025

布鲁克（BRKR）今日盘中大跌13.14%，延续了盘前的跌势。这一显著跌幅主要源于公司发布的2025年第二季度财报不及市场预期，并下调了全年业绩展望。

根据公司公布的财报，布鲁克第二季度调整后每股收益为0.32美元，远低于分析师预期的0.42美元，同比下降38.5%。季度营收为7.974亿美元，同比小幅下降0.4%，低于市场预期的8.114亿美元。值得注意的是，公司在固定汇率基础上营收下降3.3%，有机营收更是下降7.0%。

布鲁克表示，第二季度业绩下滑主要是由于关税和强劲汇率逆风无法通过价格、供应链及成本缓解措施得到补偿。此外，公司的布鲁克科学仪器(BSI)和BEST部门营收分别下降7.2%和4.8%，反映出公司核心业务面临挑战。尽管CALID集团在固定汇率基础上实现低两位数营收增长，但生命科学质谱业务表现疲软，部分抵消了增长。

面对当前的经营压力，布鲁克宣布启动一项规模显著扩大的成本节约计划，预期在2026财年实现1亿至1.2亿美元的年度成本削减。然而，公司同时下调了全年业绩展望，调整后每股收益预期降至1.95-2.05美元区间。这一系列消息引发了投资者对公司短期内改善业绩能力的担忧，导致股价大幅下挫。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1139940196"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139940196\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139940196?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-08-04 21:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139940196","market":"nz","top_or_hot":-1,"title":"异动解读 | 布鲁克股价盘中大跌13.14%，二季度业绩不及预期且下调全年展望","media":"异动解读","content":"<p>布鲁克（BRKR）今日盘中大跌13.14%，延续了盘前的跌势。这一显著跌幅主要源于公司发布的2025年第二季度财报不及市场预期，并下调了全年业绩展望。</p>\n\n<p>根据公司公布的财报，布鲁克第二季度调整后每股收益为0.32美元，远低于分析师预期的0.42美元，同比下降38.5%。季度营收为7.974亿美元，同比小幅下降0.4%，低于市场预期的8.114亿美元。值得注意的是，公司在固定汇率基础上营收下降3.3%，有机营收更是下降7.0%。</p>\n\n<p>布鲁克表示，第二季度业绩下滑主要是由于关税和强劲汇率逆风无法通过价格、供应链及成本缓解措施得到补偿。此外，公司的布鲁克科学仪器(BSI)和BEST部门营收分别下降7.2%和4.8%，反映出公司核心业务面临挑战。尽管CALID集团在固定汇率基础上实现低两位数营收增长，但生命科学质谱业务表现疲软，部分抵消了增长。</p>\n\n<p>面对当前的经营压力，布鲁克宣布启动一项规模显著扩大的成本节约计划，预期在2026财年实现1亿至1.2亿美元的年度成本削减。然而，公司同时下调了全年业绩展望，调整后每股收益预期降至1.95-2.05美元区间。这一系列消息引发了投资者对公司短期内改善业绩能力的担忧，导致股价大幅下挫。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 布鲁克股价盘中大跌13.14%，二季度业绩不及预期且下调全年展望</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 布鲁克股价盘中大跌13.14%，二季度业绩不及预期且下调全年展望\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-08-04 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>布鲁克（BRKR）今日盘中大跌13.14%，延续了盘前的跌势。这一显著跌幅主要源于公司发布的2025年第二季度财报不及市场预期，并下调了全年业绩展望。</p>\n\n<p>根据公司公布的财报，布鲁克第二季度调整后每股收益为0.32美元，远低于分析师预期的0.42美元，同比下降38.5%。季度营收为7.974亿美元，同比小幅下降0.4%，低于市场预期的8.114亿美元。值得注意的是，公司在固定汇率基础上营收下降3.3%，有机营收更是下降7.0%。</p>\n\n<p>布鲁克表示，第二季度业绩下滑主要是由于关税和强劲汇率逆风无法通过价格、供应链及成本缓解措施得到补偿。此外，公司的布鲁克科学仪器(BSI)和BEST部门营收分别下降7.2%和4.8%，反映出公司核心业务面临挑战。尽管CALID集团在固定汇率基础上实现低两位数营收增长，但生命科学质谱业务表现疲软，部分抵消了增长。</p>\n\n<p>面对当前的经营压力，布鲁克宣布启动一项规模显著扩大的成本节约计划，预期在2026财年实现1亿至1.2亿美元的年度成本削减。然而，公司同时下调了全年业绩展望，调整后每股收益预期降至1.95-2.05美元区间。这一系列消息引发了投资者对公司短期内改善业绩能力的担忧，导致股价大幅下挫。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRKR","symbol_name":"布鲁克","start_time":0,"source_url":"","article_id":"1139940196","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139940196","pubTimestamp":1754314721,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"布鲁克今日盘中大跌13.14%，延续了盘前的跌势。这一显著跌幅主要源于公司发布的2025年第二季度财报不及市场预期，并下调了全年业绩展望。根据公司公布的财报，布鲁克第二季度调整后每股收益为0.32美元，远低于分析师预期的0.42美元，同比下降38.5%。布鲁克表示，第二季度业绩下滑主要是由于关税和强劲汇率逆风无法通过价格、供应链及成本缓解措施得到补偿。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BRKR":"布鲁克"},"translate_title":"Interpretation of changes | Bruker's stock price fell 13.14% intraday, second-quarter performance fell short of expectations and lowered its full-year outlook","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRKR":1},"content_text":"布鲁克（BRKR）今日盘中大跌13.14%，延续了盘前的跌势。这一显著跌幅主要源于公司发布的2025年第二季度财报不及市场预期，并下调了全年业绩展望。\n根据公司公布的财报，布鲁克第二季度调整后每股收益为0.32美元，远低于分析师预期的0.42美元，同比下降38.5%。季度营收为7.974亿美元，同比小幅下降0.4%，低于市场预期的8.114亿美元。值得注意的是，公司在固定汇率基础上营收下降3.3%，有机营收更是下降7.0%。\n布鲁克表示，第二季度业绩下滑主要是由于关税和强劲汇率逆风无法通过价格、供应链及成本缓解措施得到补偿。此外，公司的布鲁克科学仪器(BSI)和BEST部门营收分别下降7.2%和4.8%，反映出公司核心业务面临挑战。尽管CALID集团在固定汇率基础上实现低两位数营收增长，但生命科学质谱业务表现疲软，部分抵消了增长。\n面对当前的经营压力，布鲁克宣布启动一项规模显著扩大的成本节约计划，预期在2026财年实现1亿至1.2亿美元的年度成本削减。然而，公司同时下调了全年业绩展望，调整后每股收益预期降至1.95-2.05美元区间。这一系列消息引发了投资者对公司短期内改善业绩能力的担忧，导致股价大幅下挫。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}